Clinical characteristics influence screening intervals for diabetic retinopathy

Diabetologia

Volumn 56, Issue 10, 2013, Pages 2147-2152

  Porta, Massimo ^a   Maurino, Mauro ^a   Severini, Sara ^a   Lamarmora, Elena ^a   Trento, Marina ^a   Sitia, Elena ^a   Coppo, Eleonora ^a   Raviolo, Alessandro ^a   Carbonari, Stefania ^a   Montanaro, Marcello ^a   Palanza, Lorenza ^a   Dalmasso, Paola ^b   Cavallo, Franco ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Blindness prevention; Diabetic retinopathy; Retinal screening; Screening; Type 1 diabetes; Type 2 diabetes

Indexed keywords

INSULIN;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT SAFETY; PRIORITY JOURNAL; RETINA EXAMINATION; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST;

ADULT; BLINDNESS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE;

EID: 84890130127     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2989-7     Document Type: Article

References (26)

1. Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227-1239
2. American Diabetes Association (2012) Standards of medical care in diabetes-2012. Diabetes Care 35(suppl 1):S11-S63
3. NICE (2002) Management of type 2 diabetes - screening and early management. Available from http://nice.org.uk/nicemedia/pdf/ diabetesretinopathyguideline.pdf, accessed 3 March 2013
4. Retinopathy Working Party (1991) A protocol for screening for diabetic retinopathy in Europe. Diabet Med 8:263-267
5. Kohner EM, Porta M (1992) Screening for diabetic retinopathy in Europe: a field guide-book. World Health Organization, Copenhagen
6. Younis N, Broadbent DM, Vora JP, Harding SP (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361:195-200
7. Vijian S, Hofer TP, Hayward RA (2000) Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 283:889-896
8. Maguire A, Chan A, Cusumano J et al (2005) The case for biennial retinopathy screening in children and adolescents. Diabetes Care 28:509-513
9. Agardh E, Tarabat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318-1319
10. Aspelund T, Thornórisdóttir O, Olafsdottir E et al (2011) Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia 54:2525-2532
11. Chalk D, Pitt M, Vaidya B, Stein K (2012) Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy? Diabetes Care 35:1663-1668
12. Thomas RL, Dunstan F, Luzio SD et al (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 344:e874
13. Gibbins RL, Owens DR, Allen JC, Eastman L (1998) Practical application of the European Field Guide in screening retinopathy by using ophthalmoscopy and 35 mm retinal slides. Diabetologia 41:59-64
14. Agardh E, Agardh CD, Hansson-Lundblad C (1993) The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 10:555-559
15. Backlund LB, Algvere PV, Rosenqvist U (1994) New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 14:732-740
16. Sivieri R, Rovera A, Porta M (1995) SEE (Save Eyes in Europe): the London protocol in software. Giornale Italiano di Diabetologia 15(Suppl):37-38
17. Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic colour fundus photographs - an extension of the modified Airlie House classification. ETDRS report no 10. Ophthalmology 98:786-806
18. Stratton I, Kohner EM, Aldington SJ et al (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44:156-163
19. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjølie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38:437-444
20. Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E (2000) Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 78:374-385
21. Hansson-Lundblad C, Holm K, Agardh CD, Agardh E (2002) A small number of older type 2 diabetic patients end up visually impaired despite regular photographic screening and laser treatment for diabetic retinopathy. Acta Ophthalmol Scand 80:310-315
22. (1994) Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94, series 1: programs and collection procedures. Vital Health Stat 32: 1-407
23. Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings. DRS report no. 8. Ophthalmology 88:583-600
24. Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy. ETDRS report no. 9. Ophthalmology 98:766-785
25. Stratton IM, Aldington SJ, Taylor DJ, Adler AI, Scanlon PH (2013) A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care 36:580-585
26. Hutchinson A, McIntosh A, Peters J et al (2000) Effectiveness of screening and monitoring tests for diabetic retinopathy. A systematic review. Diabet Med 17:495-506